These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15604942)

  • 1. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
    Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA
    Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
    Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
    Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
    Listewnik MH; Birkenfeld B; Foszczyńska-Kłoda M; Listewnik MJ; Piwowarska-Bilska H; Zorga P
    Ann Acad Med Stetin; 2011; 57(1):73-8. PubMed ID: 22593995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
    Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA
    Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
    Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Drucker MJ; Livingston RB
    Cancer; 1999 Jun; 85(11):2410-23. PubMed ID: 10357412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
    Evangelista L; Cervino AR; Michieletto S; Saibene T; Orvieto E; Bozza F; Ghiotto C
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):205-215. PubMed ID: 25501326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report.
    Grosso M; Imran MB; Volterrani D; Roncella M; Abufalgha K; Grassetto G; Al-Nahhas A; Rubello D; Mariani G
    Nucl Med Rev Cent East Eur; 2008; 11(2):70-2. PubMed ID: 19585458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
    Liu ZZ; Lu ZD; Zhang HW; Yang H; Liu H; Li LF; Li WL; Cui SD
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
    Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
    Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Guo C; Zhang C; Liu J; Tong L; Huang G
    Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
    Du C; Ying H; Zhou J; Jiang J; Liu C; Chen J; Wang X; Hu C
    Med Oncol; 2014 Feb; 31(2):833. PubMed ID: 24402323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
    J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer.
    Kim R; Osaki A; Hirai T; Toge T
    Breast Cancer; 2002; 9(3):240-7. PubMed ID: 12185336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
    Cwikla JB; Buscombe JR; Barlow RV; Kelleher SM; Parbhoo SP; Crow J; Deery A; Jones AL; Hilson AJ
    Eur J Nucl Med; 1997 Sep; 24(9):1175-8. PubMed ID: 9283114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.